MO35-3 Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib
- Resource Type
- Abstract
- Source
- In
Annals of Oncology November 2023 34 Supplement 3:S1418-S1418 - Subject
- Language
- ISSN
- 0923-7534